An Efficacy and Safety Study of Basimglurant (NOE-101) in Patients With Trigeminal Neuralgia.
An Efficacy and Safety Study of Basimglurant (NOE-101) in Patients With Trigeminal Neuralgia.
Active, not recruiting · NCT05217628 · Registry updated 2026-01-23Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| An Efficacy and Safety Study of Basimglurant (NOE-101) in Patients With Trigeminal Neuralgia. | Stomatognathic Diseases, cranial nerve neuropathy, facial nerve disorder, facial neuralgia, mouth disorder, nervous system disorder, trigeminal nerve disorder, trigeminal neuralgia | Active, not recruiting | Phase 2 / Phase 3 | 2026-01-23 | NCT05217628 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Noema Pharma AG | 2 |
34 results · Page 1 of 2
Research sites
Swipe the table sideways for more columns.